Iron modulates cell survival in a Ras- and MAPK-dependent manner in ovarian cells

Cell Death and Disease

Volumn 4, Issue 4, 2013, Pages

  Bauckman, K A ^a   Haller, E ^b   Flores, I ^c   Nanjundan, M ^b  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c PONCE SCHOOL OF MEDICINE   (Puerto Rico)

Author keywords

Iron (ferric ammonium citrate); Lysosomes; MAP kinase; Ovarian cancer; Ras

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; AUTOPHAGY PROTEIN 5; AUTOPHAGY PROTEIN 7; BECLIN 1; DEFEROXAMINE; FERRIC AMMONIUM CITRATE; HEME OXYGENASE 1; IRON; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN; RAS PROTEIN; UNCLASSIFIED DRUG; CHLOROQUINE; DEFEROXAMINE MESYLATE; PEPTIDES AND PROTEINS; PHOSPHATIDYLINOSITOL 3 KINASE; TRANSCRIPTION FACTOR NRF2; 1,3 BUTADIENE DERIVATIVE; APOPTOSIS REGULATORY PROTEIN; ATG5 PROTEIN, HUMAN; ATG7 PROTEIN, HUMAN; BECN1 PROTEIN, HUMAN; FERRIC ION; MAP1LC3A PROTEIN, HUMAN; MEMBRANE PROTEIN; MICROTUBULE ASSOCIATED PROTEIN; NITRILE; QUATERNARY AMMONIUM DERIVATIVE; UBIQUITIN PROTEIN LIGASE;

ARTICLE; AUTOPHAGY; CELL ADHESION; CELL DEATH; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; IN VITRO STUDY; LYSOSOME; OVARY CANCER; OVARY CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSMISSION ELECTRON MICROSCOPY; AUTOPHAGOSOME; CANCER CELL; CELL FUNCTION; CELL GROWTH; CYTOPLASM; DRUG ANTAGONISM; DRUG EFFECT; ENDOMETRIUM CELL; EPITHELIUM CELL; ONCOGENE H RAS; ONCOGENE RAS; SIGNAL TRANSDUCTION; GENETICS; METABOLISM; OVARY TUMOR; PATHOLOGY; TUMOR CELL LINE;

APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; BUTADIENES; CELL LINE, TUMOR; CELL SURVIVAL; CLASS III PHOSPHATIDYLINOSITOL 3-KINASES; FEMALE; FERRIC COMPOUNDS; HEME OXYGENASE-1; HUMANS; LYSOSOMES; MEMBRANE PROTEINS; MICROTUBULE-ASSOCIATED PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASES; NITRILES; OVARIAN NEOPLASMS; QUATERNARY AMMONIUM COMPOUNDS; RAS PROTEINS; UBIQUITIN-ACTIVATING ENZYMES;

EID: 84879721811     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2013.87     Document Type: Article

References (57)

1. Hwang KE, Na KS, Park DS, Choi KH, Kim BR, Shim H et al. Apoptotic induction by simvastatin in human lung cancer A549 cells via Akt signaling dependent down-regulation of survivin. Invest New Drugs 2011; 29: 945-952
2. Demierre MF, Higgins PD, Gruber SB, Hawk E, Lippman SM. Statins and cancer prevention. Nat Rev Cancer 2005; 5: 930-942
3. Chan KK, Oza AM, Siu LL. The statins as anticancer agents. Clin Cancer Res 2003; 9: 10-19
4. Campbell MJ, Esserman LJ, Zhou Y, Shoemaker M, Lobo M, Borman E et al. Breast cancer growth prevention by statins. Cancer Res 2006; 66: 8707-8714
5. Fromigue O, Hay E, Modrowski D, Bouvet S, Jacquel A, Auberger P et al. RhoA GTPase inactivation by statins induces osteosarcoma cell apoptosis by inhibiting p42/p44-MAPKs-Bcl-2 signaling independently of BMP-2 and cell differentiation. Cell Death Differ 2006; 13: 1845-1856
6. Jiang Z, Zheng X, Lytle RA, Higashikubo R, Rich KM. Lovastatin-Induced up-regulation of the BH3-only protein, Bim, and cell death in glioblastoma cells. J Neurochem 2004; 89: 168-178
7. Ukomadu C, Dutta A. p21-dependent inhibition of colon cancer cell growth by mevastatin is independent of inhibition of G1 cyclin-dependent kinases. J Biol Chem 2003; 278: 43586-43594
8. Crick DC, Andres DA, Danesi R, Macchia M, Waechter CJ. Geranylgeraniol overcomes the block of cell proliferation by lovastatin in C6 glioma cells. J Neurochem 1998; 70: 2397-2405
9. Jakobisiak M, Bruno S, Skierski JS, Darzynkiewicz Z. Cell cycle-specific effects of lovastatin. Proc Natl Acad Sci USA 1991; 88: 3628-3632
10. Wu J, Wong WW, Khosravi F, Minden MD, Penn LZ. Blocking the Raf/MEK/ERK pathway sensitizes acute myelogenous leukemia cells to lovastatin-Induced apoptosis. Cancer Res 2004; 64: 6461-6468
11. Gniadecki R. Depletion of membrane cholesterol causes ligand-Independent activation of Fas and apoptosis. Biochem Biophys Res Commun 2004; 320: 165-169
12. Hentosh P, Yuh SH, Elson CE, Peffley DM. Sterol-Independent regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in tumor cells. Mol carcinogen 2001; 32: 154-166
13. Jakobisiak M, Golab J. Potential antitumor effects of statins (Review). Int J Oncol 2003; 23: 1055-1069
14. Wong WW, Dimitroulakos J, Minden MD, Penn LZ. HMG-CoA reductase inhibitors and the malignant cell: The statin family of drugs as triggers of tumor-specific apoptosis. Leukemia 2002; 16: 508-519
15. Strandberg TE, Pyorala K, Cook TJ, Wilhelmsen L, Faergeman O, Thorgeirsson G et al. Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S). Lancet 2004; 364: 771-777
16. Emberson JR, Kearney PM, Blackwell L, Newman C, Reith C, Bhala N et al. Lack of effect of lowering LDL cholesterol on cancer: Meta-Analysis of individual data from 175,000 people in 27 randomised trials of statin therapy. PloS One 2012; 7: E29849
17. Brusca JS, Radolf JD. Isolation of integral membrane proteins by phase partitioning with Triton X-114. Methods Enzymol 1994; 228: 182-193
18. Allal C, Favre G, Couderc B, Salicio S, Sixou S, Hamilton AD et al. RhoA prenylation is required for promotion of cell growth and transformation and cytoskeleton organization but not for induction of serum response element transcription. J Biol Chem 2000; 275: 31001-31008
19. Bordier C. Phase separation of integral membrane proteins in Triton X-114 solution. J Biol Chem 1981; 256: 1604-1607
20. Anderson RG. The caveolae membrane system. Annu Rev Biochem 1998; 67: 199-225
21. Brown DA, London E. Functions of lipid rafts in biological membranes. Annu Rev Cell Dev Biol 1998; 14: 111-136
22. Simons K, Ikonen E. Functional rafts in cell membranes. Nature 1997; 387: 569-572
23. Waugh MG, Hsuan JJ. Preparation of membrane rafts. Methods Mol Biol 2009; 462: 403-414
24. Golub T, Wacha S, Caroni P. Spatial and temporal control of signaling through lipid rafts. Curr Opin Neurobiol 2004; 14: 542-550
25. Turner SJ, Zhuang S, Zhang T, Boss GR, Pilz RB. Effects of lovastatin on Rho isoform expression, activity, and association with guanine nucleotide dissociation inhibitors. Biochem Pharmacol 2008; 75: 405-413
26. Kim JS, Diebold BA, Kim JI, Kim J, Lee JY, Park JB. Rho is involved in superoxide formation during phagocytosis of opsonized zymosans. J Biol Chem 2004; 279: 21589-21597
27. Bokoch GM, Diebold BA. Current molecular models for NADPH oxidase regulation by Rac GTPase. Blood 2002; 100: 2692-2696
28. Bishop AL, Hall A. Rho GTPases and their effector proteins. Biochem J 2000; 348(Pt 2): 241-255
29. Benhar M, Dalyot I, Engelberg D, Levitzki A. Enhanced ROS production in oncogenically transformed cells potentiates c-Jun N-Terminal kinase and p38 mitogen-Activated protein kinase activation and sensitization to genotoxic stress. Mol Cell Biol 2001; 21: 6913-6926
30. Maundrell K, Antonsson B, Magnenat E, Camps M, Muda M, Chabert C et al. Bcl-2 undergoes phosphorylation by c-Jun N-Terminal kinase/stress-Activated protein kinases in the presence of the constitutively active GTP-binding protein Rac1. J Biol Chem 1997; 272: 25238-25242
31. Milne DM, Campbell LE, Campbell DG, Meek DW. p53 is phosphorylated in vitro and in vivo by an ultraviolet radiation-Induced protein kinase characteristic of the c-Jun kinase, JNK1. J Biol Chem 1995; 270: 5511-5518
32. Whitfield J, Neame SJ, Paquet L, Bernard O, Ham J. Dominant-negative c-Jun promotes neuronal survival by reducing BIM expression and inhibiting mitochondrial cytochrome c release. Neuron 2001; 29: 629-643
33. Herrero-Martin G, Lopez-Rivas A. Statins activate a mitochondria-operated pathway of apoptosis in breast tumor cells by a mechanism regulated by ErbB2 and dependent on the prenylation of proteins. FEBS Letters 2008; 582: 2589-2594
34. Cafforio P, Dammacco F, Gernone A, Silvestris F. Statins activate the mitochondrial pathway of apoptosis in human lymphoblasts and myeloma cells. Carcinogenesis 2005; 26: 883-891
35. van de Donk NW, Kamphuis MM, van Kessel B, Lokhorst HM, Bloem AC. Inhibition of protein geranylgeranylation induces apoptosis in myeloma plasma cells by reducing Mcl-1 protein levels. Blood 2003; 102: 3354-3362
36. Zhong WB, Wang CY, Chang TC, Lee WS. Lovastatin induces apoptosis of anaplastic thyroid cancer cells via inhibition of protein geranylgeranylation and de novo protein synthesis. Endocrinology 2003; 144: 3852-3859
37. Dimitroulakos J, Marhin WH, Tokunaga J, Irish J, Gullane P, Penn LZ et al. Microarray and biochemical analysis of lovastatin-Induced apoptosis of squamous cell carcinomas. Neoplasia 2002; 4: 337-346
38. Xia Z, Tan MM, Wong WW, Dimitroulakos J, Minden MD, Penn LZ. Blocking protein geranylgeranylation is essential for lovastatin-Induced apoptosis of human acute myeloid leukemia cells. Leukemia 2001; 15: 1398-1407
39. Dransart E, Olofsson B, Cherfils J. RhoGDIs revisited: Novel roles in Rho regulation. Traffic 2005; 6: 957-966
40. Orita S, Kaibuchi K, Kuroda S, Shimizu K, Nakanishi H, Takai Y. Comparison of kinetic properties between two mammalian ras p21 GDP/GTP exchange proteins, ras guanine nucleotide-releasing factor and smg GDP dissociation stimulation. J Biol Chem 1993; 268: 25542-25546
41. Cordle A, Koenigsknecht-Talboo J, Wilkinson B, Limpert A, Landreth G. Mechanisms of statin-mediated inhibition of small G-protein function. J Biol Chem 2005; 280: 34202-34209
42. Khan OM, Ibrahim MX, Jonsson IM, Karlsson C, Liu M, Sjogren AK et al. Geranylgeranyltransferase type I (GGTase-I) deficiency hyperactivates macrophages and induces erosive arthritis in mice. J Clin Invest 2011; 121: 628-639
43. Von Zee CL, Stubbs EB Jr. Geranylgeranylation facilitates proteasomal degradation of rho G-proteins in human trabecular meshwork cells. Invest Ophth Vis Sci 2011; 52: 1676-1683
44. Stamatakis K, Cernuda-Morollon E, Hernandez-Perera O, Perez-Sala D. Isoprenylation of RhoB is necessary for its degradation: A novel determinant in the complex regulation of RhoB expression by the mevalonate pathway. J Biol Chem 2002; 277: 49389-49396
45. O'Donnell BV, Tew DG, Jones OT, England PJ. Studies on the inhibitory mechanism of iodonium compounds with special reference to neutrophil NADPH oxidase. Biochem J 1993; 290(Pt 1): 41-49
46. Wong CH, Iskandar KB, Yadav SK, Hirpara JL, Loh T, Pervaiz S. Simultaneous induction of non-canonical autophagy and apoptosis in cancer cells by ROS-dependent ERK and JNK activation. PloS One 2010; 5: E9996
47. Shenoy K, Wu Y, Pervaiz S. LY303511 enhances TRAIL sensitivity of SHEP-1 neuroblastoma cells via hydrogen peroxide-mediated mitogen-Activated protein kinase activation and up-regulation of death receptors. Cancer Res 2009; 69: 1941-1950
48. Koyuturk M, Ersoz M, Altiok N. Simvastatin induces apoptosis in human breast cancer cells: P53 and estrogen receptor independent pathway requiring signalling through JNK. Cancer Lett 2007; 250: 220-228
49. Koyuturk M, Ersoz M, Altiok N. Simvastatin induces proliferation inhibition and apoptosis in C6 glioma cells via c-jun N-Terminal kinase. Neurosci Lett 2004; 370: 212-217
50. Zhang S, Wang XL, Gan YH, Li SL. Activation of c-Jun N-Terminal kinase is required for mevastatin-Induced apoptosis of salivary adenoid cystic carcinoma cells. Anticancer Drug 2010; 21: 678-686
51. Liu H, Liang SL, Kumar S, Weyman CM, Liu W, Zhou A. Statins induce apoptosis in ovarian cancer cells through activation of JNK and enhancement of Bim expression. Cancer Chemother Pharmacol 2009; 63: 997-1005
52. Becker EB, Howell J, Kodama Y, Barker PA, Bonni A. Characterization of the c-Jun N-Terminal kinase-BimEL signaling pathway in neuronal apoptosis. J Neurosci 2004; 24: 8762-8770
53. Harris CA, Johnson EM Jr. BH3-only Bcl-2 family members are coordinately regulated by the JNK pathway and require Bax to induce apoptosis in neurons. J Biol Chem 2001; 276: 37754-37760
54. Putcha GV, Moulder KL, Golden JP, Bouillet P, Adams JA, Strasser A et al. Induction of BIM, a proapoptotic BH3-only BCL-2 family member, is critical for neuronal apoptosis. Neuron 2001; 29: 615-628
55. Czabotar PE, Colman PM, Huang DC. Bax activation by Bim? Cell Death Differ 2009; 16: 1187-1191
56. Clement MV, Ponton A, Pervaiz S. Apoptosis induced by hydrogen peroxide is mediated by decreased superoxide anion concentration and reduction of intracellular milieu. FEBS Lett 1998; 440: 13-18
57. Chen ZX, Pervaiz S. Bcl-2 induces pro-oxidant state by engaging mitochondrial respiration in tumor cells. Cell Death Differ 2007; 14: 1617-1627